Weizheng Xu
Overview
Explore the profile of Weizheng Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu W, Cao Y, Shi H, Jia X, Zheng Y, Tan Z, et al.
Talanta
. 2025 Mar;
291:127895.
PMID: 40056654
The limitations of skin-interfaced sweat monitoring are mainly reflected in the effective collection of sweat and the high sensitivity of the detection. This work proposes a new type of sweat...
2.
Xu C, Shi H, Tan Z, Zheng Y, Xu W, Dan Z, et al.
Analyst
. 2024 Nov;
149(23):5591-5616.
PMID: 39523834
Microfluidic systems incorporating magnetic droplets have emerged as a focal point of significant interest within the biomedical domain. The allure of these systems lies in their capacity to offer precise...
3.
Drel V, Pacher P, Stavniichuk R, Xu W, Zhang J, Kuchmerovska T, et al.
Int J Mol Med
. 2011 May;
28(4):629-35.
PMID: 21617845
Poly(ADP-ribose) polymerase (PARP) activation has been implicated in the pathogenesis of diabetic complications, including nephropathy and peripheral neuropathy. This study aimed at evaluating the manifestations of both complications in diabetic...
4.
Yao H, Xu W, Shi X, Zhang Z
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev
. 2011 Mar;
29(1):1-31.
PMID: 21424974
Dietary agents identified from fruits and vegetables contribute to keeping balanced cell proliferation and preventing cell carcinogenesis. Dietary flavonoids, combined with other components such as various vitamins, play an important...
5.
Drel V, Lupachyk S, Shevalye H, Vareniuk I, Xu W, Zhang J, et al.
Endocrinology
. 2010 Apr;
151(6):2547-55.
PMID: 20357221
This study evaluated poly(ADP-ribose) polymerase (PARP) inhibition as a new therapeutic approach for peripheral diabetic neuropathy using clinically relevant animal model and endpoints, and nitrotyrosine (NT), TNF-alpha, and nitrite/nitrate as...
6.
Shevalye H, Stavniichuk R, Xu W, Zhang J, Lupachyk S, Maksimchyk Y, et al.
Biochem Pharmacol
. 2009 Dec;
79(7):1007-14.
PMID: 19945439
Evidence for the important role for poly(ADP-ribose) polymerase (PARP) in the pathogenesis of diabetic nephropathy is emerging. We previously reported that PARP inhibitors counteract early Type 1 diabetic nephropathy. This...
7.
Drel V, Xu W, Zhang J, Pavlov I, Shevalye H, Slusher B, et al.
Endocrinology
. 2009 Oct;
150(12):5273-83.
PMID: 19854869
This study was aimed at evaluating the role for poly(ADP-ribose) polymerase (PARP) in early nephropathy associated with type 1 diabetes. Control and streptozotocin-diabetic rats were maintained with or without treatment...
8.
Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427
Khan K, Araki K, Wang D, Li G, Li X, Zhang J, et al.
Head Neck
. 2009 Aug;
32(3):381-91.
PMID: 19672867
Background: In this study, we tested the ability of a novel poly(adenosine diphosphate ribose) polymerase (PARP) inhibitor, 10-(4-methyl-piperazin-1-ylmethyl)-2H-7-oxa-1,2-diaza-benzo[de]-anthracen-3-one (GPI-15427), to enhance the effect of radiotherapy in a xenograft model of...
9.
Lacal P, Tentori L, Muzi A, Ruffini F, Dorio A, Xu W, et al.
Int J Oncol
. 2009 Feb;
34(3):861-72.
PMID: 19212692
Poly(ADP-ribose) polymerase (PARP) is a family of nuclear proteins which regulate a number of cell functions, such as DNA repair, transcription, remodelling of chromatin structure, cell division and cell death....
10.
Drel V, Xu W, Zhang J, Kador P, Ali T, Shin J, et al.
Invest Ophthalmol Vis Sci
. 2008 Dec;
50(4):1778-90.
PMID: 19098320
Purpose: This study evaluated the role for poly(ADP-ribose) polymerase (PARP) in diabetes-induced cataractogenesis and early retinal changes. Methods: Control and streptozotocin (STZ)-diabetic rats were treated with or without the PARP...